Author
Number of items: 22.
2025
From lockdown to Liberation: How inflexible thinking, obsessive-compulsive and affective symptoms shape pandemic adjustment. (2025)
Aaron Clarke,
Naomi Fineberg,
Luca Pellegrini,
Rodolfo Leuzzi
and
Keith Laws
picture_as_pdf
Meta-analysis of age at help-seeking and duration of untreated illness (DUI) in obsessive-compulsive disorder (OCD): The need for early interventions. (2025)
Luca Pellegrini,
Sofia Giobelli,
Sofia Burato,
Gabriele di Salvo,
Giuseppe Maina
and
Umberto Albert
Single-Dose (10mg) Psilocybin Reduces Symptoms in Adults with Obsessive-Compulsive Disorder: A Pharmacological Challenge Study. (2025)
Luca Pellegrini,
Naomi Fineberg,
Sorcha O'Connor,
Ana Maria Frota Lisboa Pereira De Souza,
Kate Godfrey,
Joseph Peill,
Mairead Healy,
Cyrus Rohani-Shukla,
Hakjun Lee,
Robin Carhart-Harris,
Trevor W Robbins,
David Nutt
and
David Erritzoe
picture_as_pdf
2024
Participation in an Italian cancer screening program among people with psychiatric diagnoses: a retrospective cohort study. (2024)
S. Burato,
A. D'Aietti,
A. Paci,
L. Pellegrini,
C. Sindici,
C. Dellach,
S. Negro
and
U. Albert
Obsessive–Compulsive Symptoms in the General Population Under Stressful Conditions: Lessons Learned from the COVID-19 Pandemic. (2024)
Luca Pellegrini,
Umberto Albert,
Claudia Carmassi,
Giuseppe Carrà,
Francesca Cirulli,
Bernardo Dell’Osso,
Matteo Di Vincenzo,
Mario Luciano,
Maria Giulia Nanni,
Maurizio Pompili,
Gabriele Sani,
Alfonso Tortorella,
Umberto Volpe,
Andrea Fiorillo
and
Gaia Sampogna
How to Treat Compulsive Facets of Behavioural Addictions. (2024)
Naomi Fineberg,
Luca Pellegrini,
Jeremy Solly,
Davis N. Mpavaenda,
Samuel R Chamberlain
and
J. E. Grant
The Inflexible Mind: A Critical Factor in Understanding and Addressing COVID-19 Vaccine Hesitancy. (2024)
Luca Pellegrini,
Aaron Clarke,
Naomi Fineberg
and
Keith Laws
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System. (2024)
Michele Fusaroli,
Stefano Polizzi,
Luca Menestrina,
Valentina Giunchi,
Luca Pellegrini,
Emanuel Raschi,
Daniel Weintraub,
Maurizio Recanatini,
Gastone Castellani,
Fabrizio De Ponti
and
Elisabetta Poluzzi
Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial. (2024)
Daniela Adamo,
Federica Canfora,
Giuseppe Pecoraro,
Stefania Leuci,
Noemi Coppola,
Gaetano Marenzi,
Giulia Ottaviani,
Katia Rupel,
Luca Pellegrini,
Massimo Aria,
Luca D’Aniello,
Michele Davide Mignogna
and
Umberto Albert
Cognitive inflexibility, obsessive-compulsive symptoms and traits and poor post-pandemic adjustment. (2024)
Ana Maria Frota Lisboa Pereira De Souza,
Luca Pellegrini
and
Naomi Fineberg
picture_as_pdf
Borderline personality disorder and aggressive behavior: A study based on the DSM-5 alternative model. (2024)
Anna Caterina Leucci,
Ilaria De Giorgi,
Lorenzo Pelizza,
Biancamaria Bortolotti,
Francesca D'Adda,
Lorenzo Gammino,
Sara Gibiino,
Loredana Lia,
Margherita Magro,
Luca Pellegrini
and
Marco Menchetti
2023
Selective serotonin reuptake inhibitors (SSRIs) may improve behavioral inhibition in patients with obsessive compulsive disorder: a feasibility study. (2023)
L. Pellegrini,
R. Jemma,
D. Wellsted
and
N. Fineberg
Transcranial Direct Current Stimulation in Obsessive Compulsive Symptoms: A Personalised Approach. (2023)
Luca Pellegrini,
David Wellsted,
Eduardo Cinosi,
Amanda Busby,
Megan Smith
and
Naomi Fineberg
Effects of exercise on obsessive-compulsive disorder symptoms: a systematic review and meta-analysis. (2023)
Lindsay Bottoms,
Montserrat Prat Pons,
Naomi Fineberg,
Luca Pellegrini,
Oliver Fox,
David Wellsted,
Lynne M Drummond,
Jemma Reid,
David Baldwin,
Ruihua Hou,
Samuel R Chamberlain,
Nick Sireau,
Dominique Grohmann
and
Keith Laws
picture_as_pdf
Emotion dysregulation, impulsivity and anger rumination in borderline personality disorder: the role of amygdala and insula. (2023)
M. Mitolo,
F. D’Adda,
S. Evangelisti,
L. Pellegrini,
L. L. Gramegna,
C. Bianchini,
L. Talozzi,
D. N. Manners,
C. Testa,
D. Berardi,
R. Lodi,
M. Menchetti
and
C. Tonon
2022
Repetitive Transcranial Magnetic Stimulation (r-TMS) and Selective Serotonin Reuptake Inhibitor-Resistance in Obsessive-Compulsive Disorder: A Meta-Analysis and Clinical Implications. (2022)
Luca Pellegrini,
Kabir Garg,
Arun Enara,
David Shimon Gottlieb,
David Wellsted,
Umberto Albert,
Keith Laws
and
Naomi Fineberg
picture_as_pdf
Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design. (2022)
Naomi Fineberg,
Luca Pellegrini,
Aaron Clarke,
Uday Perera,
Lynne M Drummond,
Umberto Albert
and
Keith Laws
picture_as_pdf
The Inflating Impact of Waiting-List Controls on Effect Size Estimates. (2022)
Keith R. Laws,
Luca Pellegrini,
Jemma E. Reid,
Lynne M. Drummond
and
Naomi A. Fineberg
Commentary on the article: “Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation A Randomized Clinical Trial”. (2022)
Naomi Fineberg,
Eric Hollander,
Jon E Grant,
Samuel R Chamberlain,
Lynne Drummond,
Luca Pellegrini,
Keith Laws,
David Wellsted,
Jemma Reid,
Vera Nezgovorova
and
David Baldwin
New challenges in facing Cyberchondria during the COVID-19 pandemic. (2022)
Matteo Vismara,
Alberto Varinelli,
Luca Pellegrini,
Arun Enara
and
Naomi Fineberg
Individual obsessive-compulsive traits are associated with poorer adjustment to the easing of COVID-19 restrictions. (2022)
Naomi A. Fineberg,
Luca Pellegrini,
Julius Burkauskas,
Aaron Clarke
and
Keith R. Laws
